We used quantitative topographical electroencephalography (EEG) to determine the time course of changes in brain electrical activity after clonidine infusion. Twenty healthy male volunteers (aged 24 ? 5 yr) were included in the randomized, double-blind, placebocontrolled (Group 1, placebo, n = 10; Group 2, 2.0 pg/kg clonidine, n = 10) study. EEG (17 electrodes, common average reference, fast Fourier transformation, band pass 0.4-35.0 Hz) output was recorded until 145 min after drug infusion. Subjects were intermittently stimulated by verbal commands. Clonidinerelated changes resulted in attenuation of the physiological alpha fluctuations seen in untreated subjects and were most pronounced at parietooccipital (P4, 0,) recording sites. This was associated with initial maximal increases in slow wave activity (delta) almost uniformly distributed over the whole cortex, restricting with time to occipital regions (0,). The EEG mapping technique may provide more specific information about clonidine-mediated sedative effects, indicating facilitations of EEG patterns that are not homogeneously distributed.
We used quantitative topographical electroencephalography (EEG) to determine the time course of changes in brain electrical activity after clonidine infusion. Twenty healthy male volunteers (aged 24 ? 5 yr) were included in the randomized, double-blind, placebocontrolled (Group 1, placebo, n = 10; Group 2, 2.0 pg/kg clonidine, n = 10) study. EEG (17 electrodes, common average reference, fast Fourier transformation, band pass 0.4-35.0 Hz) output was recorded until 145 min after drug infusion. Subjects were intermittently stimulated by verbal commands. Clonidinerelated changes resulted in attenuation of the physiological alpha fluctuations seen in untreated subjects and were most pronounced at parietooccipital (P4, 0,) recording sites. This was associated with initial maximal increases in slow wave activity (delta) almost uniformly distributed over the whole cortex, restricting with time to occipital regions (0,). The EEG mapping technique may provide more specific information about clonidine-mediated sedative effects, indicating facilitations of EEG patterns that are not homogeneously distributed.
These EEG changes cannot be explained by physiologic changes in vigilance or by normal sleep stages because they were not observed after placebo. EEG effects seem to be unrelated to changes in hemodynamics.
Implications:
In healthy volunteers, placebo-controlled signal changes in the electroencephalogram were evaluated to quantify sedative drug effects after intravenous application of clonidine. A multichannel recording system and electroencephalogram mapping technique indicate fluctuations of electroencephalogram patterns that are not homogeneously distributed over the cortex associated with sedation.
(Anesth Analg 1998;86:202-7) C lonidine improves intraoperative cardiovascular and adrenergic stability and decreases anesthetic requirements (l-6). In humans, the topographical distribution of changes in brain electrical activity induced by clonidine given as a sole drug has not been evaluated. Multichannel electroencephalogram (EEG) recordings, in combination with computer-based power spectrum analysis, has been proposed for quantitation of changes in the topographical distribution of EEG patterns related to different states of alertness, sleepiness, and anesthesia (7). Several studies suggest that the transition from awareness to sedation is characterized by EEG slowing and a decrease in alpha activity followed by increases in theta and delta activity (8,9). Vice ueysu, an increase in wakefulness or vigilance is indicated by an increase and acceleration of alpha activity. This is associated with decreases in slow wave activity (delta and theta).
In the present study, an EEG mapping technique was used to obtain more specific information about the time course of the topographical distribution of changes in brain electrical activity after clonidine infusion (2.0 pg/kg intravenously [IV]) in healthy subjects. Using a randomized, placebo-controlled design, we investigated the time course and the topographical pattern of clonidine-related changes in brain electrical activity under awake, resting conditions. Furthermore, the effects of clonidine on the EEG response to verbal commands were evaluated. Verbal stimulation was performed at defined time points to achieve an increased state of vigilance.
Methods
This double-blind, placebo-controlled study was approved by our institutional ethics committee. After written, informed consent, 20 healthy male volunteers aged 2033 yr (24 ? 5 yr) participated in the study. All subjects were free from neurologic or other diseases 203 EEG RESPONSE TO IV CLONIDINE (ASA physical status I) and routine use of medications. All subjects arrived at the laboratory at 10 AM after an overnight sleep of at least 8 h, having refrained from alcohol, coffee, and tea for at least 24 h.
Subjects were randomly assigned to one of two groups. In Group 1 subjects (n = 10, placebo) 100 mL acetated Ringer's solution was infused IV over 10 min. In Group 2 subjects (n = 10, clonidine), 2.0 pg/kg clonidine dissolved in 100 mL acetated Ringer's solution was infused IV (syringe pump, 10 min). During the study, subjects were requested to relax with their eyes closed (supine position). Room noise was kept at a minimum. At the end of the study, subjects were requested to indicate whether they had received placebo or clonidine based on their subjective changes in vigilance or sedation.
The following variables were monitored: heart rate (HR), mean arterial blood pressure (MABP), arterial oxygen saturation (Sao,), end-tidal CO, (nasal probe), body temperature (axillary), and EEG. The EEG was recorded from 17 electrodes (16 electrodes plus reference subjected to a common average reference calculation) with EC1 ElectrodeCAPTM (EC1 Electra-Cap International, Eaton, OH) and placed according to the international lo-20 system (10,ll). For artifact control, electrooculogram (EOG) and electrocardiogram (ECG) were also monitored. The input impedance of the system was greater than 20 Ma, which guaranteed a sufficient signal-to-noise ratio for differences in electrode impedances. EEG signals were sampled via a 16-channel amplifier (band pass 0.4-35.0 Hz; sampling rate 512 Hz/12 bit) and were transmitted via optical fibers to a computer system (CateemTM; Medisyst, Linden, Germany). In each subject, EEG raw signals (EEG, EOG) were visually monitored on-line on a screen by the same observer, who was blinded to treatment. After on-line fast Fourier transformation (epoch length 4 s; digitization 256/s), spectral power was displayed on a second monitor and stored on disk. The topographical distribution of absolute power densities and their relative changes over time were calculated with respect to common average reference (11) in selected frequency bands (delta 0.4-4.5 Hz; theta 4.7-6.8 Hz; alpha 1 7.0-9.5 Hz; alpha 2 9.7-12.5 Hz; beta 1 12.7-18.5 Hz; beta 2 18.7-35.0 Hz).
After EEG baseline recordings (-15 to 0 min) had been taken, the respective drugs were infused IV over 10 min. A total observation period of 145 min included three evaluation periods: A (O-20 min), B (45-80 min), and C (105-140 min). After each resting period (A, B, and C), subjects were asked to answer simple questions about their name and age to achieve an increased state of vigilance at defined time points (Al 20-25 min; Bl 80-85 min; Cl 140-145 min after the start of drug administration).
To quantify stimulus-related changes in brain electrical activity, each 5-min interval before (AO, BO, CO) the 5 min of stimulation (Al, Bl, Cl) was evaluated. Subjects were allowed to move for at least 20 min between the eriods of EEG recording. Absolute EEG power (pV r /Hz in median [SO%] and the 25-75 percentiles) and relative changes from baseline (percentages) in the selected frequency bands were calculated. Data were averaged over 5-min intervals for all evaluation periods and given for each time point in each group (placebo, clonidine). EEG data were analyzed for the following periods: A (O-20 min, including lo-min drug infusion), B (45-80 min), C (105-140 min); and the respective 5-min periods before and after stimulation (verbal commands) (AO, BO, CO).
Statistical analysis was restricted to data collected along a frontooccipital line (F4, C.+, I',, T,, 0,), and maximal changes were registered for delta and alpha 2 subjected to analysis of variance. Statistical tests were applied to compare selected periods with baseline values (15 min) within groups (clonidine or placebo) using the ranked sum test and between groups using Wilcoxon's test. MABP, HR, Sao2, and body temperature were calculated as mean +-SD; comparisons were performed using Wilcoxon's test. Statistical significance was considered at P < 0.05.
Results
Demographic data were comparable in both groups. At the end of the EEG recording sessions, all subjects were fully awake and alert. Changes to subjective vigilance after drug administration were indicated by 8 of 20 subjects. Only 6 of these subjects belonged to the clonidine group. MABP, HR ( Fig. 1) , Sao2, and body temperature were within normal ranges and did not change over time in any group.
Periods of artifacts contaminated by muscle activity, baseline shift, ECG, arterial pulse wave, and eye movement were approximately 15% of recording time. At baseline (15 min), the maximal EEG power in delta-, theta-, alpha l-, and alpha 2-frequency bands was recorded at occipital regions (O,, 0,). Although there were interindividual differences in EEG spectral power densities, averaged baseline data in delta, theta, alpha 1, and alpha 2 power were comparable between groups. Alpha activity was the dominant rhythm in the subjects of both groups at all recording sites (Fig. 2) .
After placebo and during resting conditions without any stimulation (A, B, and C) in the selected frequency bands of delta and theta, no changes from baseline were observed over time ( CO/Cl; P < 0.05; Table 1 ) and were dominant at occipital (e.g., 0,) and parietal (e.g., P4) recording sites. Clonidine resulted in an EEG slowing ( Fig. 2 ) with increases in delta and decreases in alpha power (Fig.  3) . Increases in delta versus baseline and versus placebo were distributed over the whole cortex. Maximal changes were registered after completion of clonidine infusion and before the onset of stimulation (A0 15-20 min) ( Table 2 ). During periods with resting conditions, e.g., BO (75-80 min) and CO (135-140 min), delta was increased only at occipital regions (0,) ( Table 2 ; Fig. 3) .
After clonidine administration, quantitative alpha (alpha 1, alpha 2) fluctuations were decreased (Fig. 3) . With respect to the 5-min intervals during A, the maximal suppression in alpha 2 was observed lo-15 min after the start of infusion and preceded maximal changes in delta at A0 (15-20 min) (Fig. 4) . During resting conditions, alpha suppression compared with baseline was maximal at occipital (0,) and parietal (P4) regions, whereas frontocentral and temporal areas were not affected (Table 1) .
Verbal commands during Al, Bl, and Cl resulted in a partial reversal of the clonidine-induced shift to slow wave activity and alpha 2 suppression (Fig. 4) . During the first voice commands (Al), delta activity was still enhanced over the whole cortex and different from placebo. Delta regained baseline values comparable to those with placebo at either recording site during Bl and Cl (Table 2 ). The parietooccipital (P4, 0,) distribution of the clonidine-related alpha 2 suppression persisted during all stimulated periods (Al, Bl, Cl) ( Table 1 ). 
Discussion variables, clonidine-induced EEG changes may be
The present data demonstrate topographical EEG most likely attributed to its sedative drug effect changes after IV injection of clonidine in unstimu-(12-14).
lated, awake healthy subjects. Compared with plaThere is no available information on the time course cebo, the most striking effects of clonidine were deof topographical EEG changes after clonidine.
creases in occipital alpha power and increases in delta Changes in the spatiotemporal distribution of alpha waves distributed over the whole cortex. In both EEG patterns may be identified by brain mapping groups (placebo, clonidine) verbal commands requesttechniques, which may indicate different stages of ing simple mental tests resulted in increases in alpha vigilance and sedation or the transitional stages bepower predominantly at occipital and parietal (posttween wakefulness and sleep (8,15). Sedation or decentral) regions. However, the increase in absolute creases in vigilance have been associated with EEG alpha power was significantly attenuated in the slowing and decreases of the dominant alpha rhythm clonidine group. In the absence of changes in systemic and with additional, relatively short-lasting anterior ET AL. EEG RESPONSE TO IV CLONIDINE ANESTH ANALG 1998; 86:202-7 spread of the occipital fast alpha activity, accompanied by anteriorization of the voltage maximum (8,15). The present data cannot support these findings because no comparable variations in alpha activity were observed. This may be either due in part to the averaging process for data calculation or to the pharmacodynamic effects of clonidine, which may have attenuated small alpha fluctuations.
Results from sleep studies support our interpretation that the EEG changes we observed were actually induced by clonidine and not influenced by spontaneous variations in vigilance. Interestingly, similar EEG patterns with a transient shift to slow wave activity after clonidine administration have also been demonstrated in subjects who are falling asleep (16). Based on our study design (placebo-controlled), we conclude that the observed EEG slow wave activity was most probably induced by clonidine. No comparable increases in delta power were observed in any subject in the placebo group. However, the evaluation of clonidine-induced EEG alterations relating changes in sleep behavior to increases in total sleep time and inhibition of paradoxical sleep (rapid eye movement) (17-20) is limited. This is because subjects were awakened for assessment of stimulus-induced EEG alterations at the end of each recording session.
A drawback of the present study may be that no psychophysiological tests for the assessment of clonidine-induced changes of reaction time or vigilance were available. However, the attenuation of the alpha response to verbal commands may indicate a decreased level of vigilance, because similar electrophysiological findings have been related to drowsiness and/or sleepiness associated with increases in reaction time (12). The EEG patterns of subjects with impaired consciousness usually show an EEG desynchronization in response to external stimuli (21). In the present study, voice commands resulted in EEG changes in both groups, but these changes were significantly less pronounced after clonidine compared with placebo. The impairment in the electrophysiological arousal response seen herein indicates that the EEG may be useful in the detection of depressant drug effects. It is unclear whether the attenuation of the alpha response after clonidine represents an attenuation of selective cortical signal processing or of a nonspecific arousal phenomenon.
Clonidine, a centrally acting preferential cq adrenergic agonist, produces sedative and/or anesthetic effects that are recordable with the EEG (22) by stimulation of centrally located a,-adrenoceptors (3,4). One of the highest receptor densities has been detected in the locus coeruleus, which is the predominant noradrenergic nucleus in the brain and an important modulator of vigilance (23,24) by reducing the firing rate of noradrenergic coerulocortical neurons (18, 25) . The interruption of noradrenergic neurotransmission by clonidine may disinhibit the inhibitory interneurons, such as the GABAergic pathways, to produce central nervous system depression (26).
After oral administration of clonidine, sedative and hemodynamic effects are at a maximum after approximately two hours (12, 14) . According to a half-life of 9-12 hours, clonidine effects were elicited for up to 7 hours after dosing (14). In the present study, IV injection resulted in EEG changes within 5 to 10 minutes of the start of infusion. Maximal changes in delta and alpha activity peaked within 30 minutes, and EEG findings were different from placebo during unstimulated and stimulated conditions within the observation period of 145 minutes. The present data demonstrate that multichannel recordings may provide more specific information about time-related signal changes, indicating that the topographic representation of clonidine-mediated EEG effects may not be homogeneously distributed. Many studies have used two-channel parietal or temporal recordings, which would not detect the frontal or occipital EEG changes seen during all observation periods.
Clonidine is supposed to decrease blood pressure and HR after single doses (0.15-0.3 mg), which limits its general use in clinical practice (12, 16, 17) . The absence of hemodynamic changes in our healthy volunteers was presumably mediated by using comparably small doses of clonidine (2.0 pg/kg) and a slow infusion rate over 10 minutes. Because the hemodynamic variables did not change over time, we conclude that the long-lasting EEG changes observed in this study are independent of the cardiovascular effects of clonidine (12) (13) (14) .
In summary, the present study demonstrates that IV administration of clonidine in healthy volunteers resulted in long-lasting EEG changes represented by decreases of dominant alpha rhythms and increases in slow frequencies. These EEG changes may be a result of drug-induced reduction in sympathetic tone and sedation. The EEG arousal response to verbal commands was attenuated by clonidine. These sedative effects were observed without marked cardiovascular drug effects. Our results confirm the hypothesis of noradrenergic facilitation of EEG patterns. The topographical EEG findings demonstrate that multichannel recordings may provide more specific information about changes in regional cerebral function. Clonidine-evoked EEG changes were noted over the whole cortex with a maximum at the occipital regions. Decreases of the dominant alpha rhythm had a more posterior distribution, whereas marked increases in delta extended from occipital to parietal leads. 
